BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 33923122)

  • 1. Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies.
    López-Toro AA; Sánchez-Teba EM; Benítez-Márquez MD; Rodríguez-Fernández M
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33923122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.
    Dănescu T; Popa MA
    Global Health; 2020 Dec; 16(1):117. PubMed ID: 33302949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does chief executive compensation predict financial performance or inaccurate financial reporting in listed companies: A systematic review.
    Rousseau D; Kim BJ; Splenda R; Young S; Lee J; Beck D
    Campbell Syst Rev; 2023 Dec; 19(4):e1370. PubMed ID: 38089569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects.
    Zhong Y; Wu X
    PLoS One; 2020; 15(3):e0229739. PubMed ID: 32134951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESG performance, investor attention, and company reputation: Threshold model analysis based on panel data from listed companies in China.
    Meng T; Dato Haji Yahya MH; Ashhari ZM; Yu D
    Heliyon; 2023 Oct; 9(10):e20974. PubMed ID: 37876450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clean energy and (E)SG investing from energy and environmental linkages.
    Kanamura T
    Environ Dev Sustain; 2022 Aug; ():1-41. PubMed ID: 35966340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESG practices mitigating geopolitical risks: Implications for sustainable environmental management.
    Alnafrah I
    J Environ Manage; 2024 May; 358():120923. PubMed ID: 38652985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESG investing and the financial performance: a panel data analysis of developed REIT markets.
    Erol I; Unal U; Coskun Y
    Environ Sci Pollut Res Int; 2023 Aug; 30(36):85154-85169. PubMed ID: 37380853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environment, Social, and Governance Performance and Financial Performance With National Pension Fund Investment: Evidence From Korea.
    Son S; Kim J
    Front Psychol; 2022; 13():893535. PubMed ID: 35645904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms.
    Mohammadzadeh M; Aarabi SM; Salamzadeh J
    Daru; 2013 Aug; 21(1):65. PubMed ID: 23915467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESG did not immunize stocks during the COVID-19 crisis, but investments in intangible assets did.
    Demers E; Hendrikse J; Joos P; Lev B
    J Bus Finance Account; 2021; 48(3-4):433-462. PubMed ID: 34230747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
    Anyakora C; Ekwunife O; Alozie F; Esuga M; Ukwuru J; Onya S; Nwokike J
    BMC Health Serv Res; 2017 Sep; 17(1):665. PubMed ID: 28923044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Environmental, Social, and Governance Drive the Sustainability of Multinational Corporation's Subsidiaries? Evidence From Korea.
    Kim J; Cho E; Okafor CE; Choi D
    Front Psychol; 2022; 13():899936. PubMed ID: 35645914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of corporate charitable giving on hospitality firm performance: Doing well by doing good?
    Chen MH; Lin CP
    Int J Hosp Manag; 2015 May; 47():25-34. PubMed ID: 32287861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking the effect of ESG practices on profitability through cross-dimensional substitutability.
    Taddeo S; Agnese P; Busato F
    J Environ Manage; 2024 Feb; 352():120115. PubMed ID: 38237333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESG Investment Scale Allocation of China's Power Grid Company Using System Dynamics Simulation Modeling.
    Huang B; Wang Z; Gu Y
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From risk to resilience: Climate change risk, ESG investments engagement and Firm's value.
    Bagh T; Fuwei J; Khan MA
    Heliyon; 2024 Mar; 10(5):e26757. PubMed ID: 38463879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Relationship Between ESG Performance and Green Bond Issuance.
    Wang S; Wang D
    Front Public Health; 2022; 10():897577. PubMed ID: 35692317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of ESG Ratings On Idiosyncratic Stock Risk: The Unrated, the Good, the Bad, and the Sinners.
    Horn M
    Schmalenbach Z Betriebswirtsch Forsch; 2023 Feb; ():1-28. PubMed ID: 36844611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.